Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BIOCON    TEVA PHARMA
EQUITY SHARE DATA
    BIOCON
Mar-23
TEVA PHARMA
Dec-13
BIOCON /
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs3883,479-   
Low Rs1923,022-   
Sales per share (Unadj.) Rs93.11,996.4-  
Earnings per share (Unadj.) Rs5.4124.7-  
Cash flow per share (Unadj.) Rs14.6286.1-  
Dividends per share (Unadj.) Rs1.50109.18-  
Avg Dividend yield %0.53.4 15.4%  
Book value per share (Unadj.) Rs146.52,217.6-  
Shares outstanding (eoy) m1,200.60848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.11.6 191.2%   
Avg P/E ratio x54.126.1 207.6%  
P/CF ratio (eoy) x19.811.4 174.3%  
Price / Book Value ratio x2.01.5 134.9%  
Dividend payout %28.087.5 32.0%   
Avg Mkt Cap Rs m347,8142,756,220 12.6%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m21,8100-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m111,7421,692,969 6.6%  
Other income Rs m7,6810-   
Total revenues Rs m119,4231,692,969 7.1%   
Gross profit Rs m16,611463,620 3.6%  
Depreciation Rs m11,131136,844 8.1%   
Interest Rs m4,19033,253 12.6%   
Profit before tax Rs m8,971293,523 3.1%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m2,541-3,584 -70.9%   
Profit after tax Rs m6,430105,758 6.1%  
Gross profit margin %14.927.4 54.3%  
Effective tax rate %28.3-1.2 -2,320.0%   
Net profit margin %5.86.2 92.1%  
BALANCE SHEET DATA
Current assets Rs m123,3401,143,425 10.8%   
Current liabilities Rs m85,107997,163 8.5%   
Net working cap to sales %34.28.6 396.0%  
Current ratio x1.41.1 126.4%  
Inventory Days Days12991 142.1%  
Debtors Days Days11796 121.7%  
Net fixed assets Rs m394,078552,961 71.3%   
Share capital Rs m6,0034,167 144.1%   
"Free" reserves Rs m169,9260-   
Net worth Rs m175,9291,880,567 9.4%   
Long term debt Rs m152,905865,653 17.7%   
Total assets Rs m517,4183,868,976 13.4%  
Interest coverage x3.19.8 32.0%   
Debt to equity ratio x0.90.5 188.8%  
Sales to assets ratio x0.20.4 49.4%   
Return on assets %2.13.6 57.1%  
Return on equity %3.75.6 65.0%  
Return on capital %4.04.9 81.2%  
Exports to sales %3.10-   
Imports to sales %6.00-   
Net fx Rs m-3,1870-   
CASH FLOW
From Operations Rs m18,525269,772 6.9%  
From Investments Rs m-142,818-95,591 149.4%  
From Financial Activity Rs m130,487-323,609 -40.3%  
Net Cashflow Rs m6,411-149,429 -4.3%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare BIOCON With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare BIOCON With: PANACEA BIOTECH  JUBILANT PHARMOVA   HEMO ORGANIC  MANKIND PHARMA  SYNCOM FORMULATIONS  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.